Glossary
The state-of-the-art glossary for Waldenström’s macroglobulinemia.
Rituximab
Rituximab in the glossary for Waldenström's macroglobulinemia
Rituximab is a chimeric monoclonal antibody anti-CD20 antibody
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein, it triggers cell death. Rituximab is primarily used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. Rituximab is authorized for use in the EU.1 Rituximab is authorized for use in Australia.2
Glossary overview